Wolverine Asset Management LLC decreased its stake in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report) by 96.7% in the fourth quarter, HoldingsChannel reports. The firm owned 11,702 shares of the company’s stock after selling 338,455 shares during the period. Wolverine Asset Management LLC’s holdings in M3-Brigade Acquisition V were worth $124,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Prelude Capital Management LLC purchased a new stake in M3-Brigade Acquisition V during the third quarter valued at about $281,000. Sandia Investment Management LP purchased a new stake in shares of M3-Brigade Acquisition V in the 2nd quarter valued at approximately $334,000. Radcliffe Capital Management L.P. acquired a new position in M3-Brigade Acquisition V in the 3rd quarter worth approximately $544,000. Susquehanna International Group LLP purchased a new position in M3-Brigade Acquisition V during the 3rd quarter worth approximately $586,000. Finally, Clear Street Group Inc. acquired a new stake in M3-Brigade Acquisition V during the 3rd quarter valued at $879,000.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on MBAV shares. Wall Street Zen raised M3-Brigade Acquisition V to a “sell” rating in a research report on Saturday, March 14th. Weiss Ratings restated a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.
M3-Brigade Acquisition V Trading Up 0.2%
Shares of NASDAQ:MBAV opened at $10.80 on Friday. M3-Brigade Acquisition V Corp. has a 1 year low of $10.34 and a 1 year high of $13.73. The business has a fifty day simple moving average of $10.77 and a 200 day simple moving average of $10.69.
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
Recommended Stories
Want to see what other hedge funds are holding MBAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Free Report).
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
